TUCSON, AZ / ACCESS Newswire / June 5, 2025 / In 2025, nerve pain, often brushed off or misdiagnosed, continues to quietly disrupt millions of lives around the world. Clinically referred to as ...

A leading neurologist's "Omelet Trick" reveals how a simple breakfast change-combined with 7 potent ingredients in Nerve ...

At ASCO, researchers presented results of Phase I trials evaluating combinations of KRAS G12C inhibitors, EGFR inhibitors, and chemotherapy in colorectal cancer.

Toxicities related to Teliso-V are manageable for patients with c-Met overexpressing non-small cell lung cancer, according to ...

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

Pfizer Inc. (NYSE: PFE) today announced statistically significant and clinically meaningful survival results from the Phase 3 ...